Durango® Boot, a division of Rocky Brands, Inc., continues its support of breast cancer research with a $2,528 donation to the Stefanie Spielman Fund for Breast Cancer Research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). To date, Durango® has donated $266,058 to breast cancer research, with more than $80,000 allocated to the Spielman Fund.
“Each year, portions of sales generated from Durango®‘s pink ribbon boot are donated to organizations supporting breast cancer research,” said Erin DeLong, Durango® marketing manager. “The Stefanie Spielman Fund supports cutting-edge research projects aimed toward finding a cure, and we are proud to continue supporting these efforts this year.”
The brand donates a portion of each Durango® Benefiting Stefanie Spielman Women’s Western Boot sold to organizations supporting the fight against breast cancer. This donation will support ongoing clinical trials, research and new technologies at the OSUCCC.
The Durango® Benefiting Stefanie Spielman Women’s Western Boot features a translucent rubber outsole with a pink ribbon graphic, a symbol for breast cancer awareness and support for those who have been affected by the disease. The boots retail for $166.
About the Stefanie Spielman Fund
In 1998, Stefanie Spielman was diagnosed with breast cancer at the age of 30 and lost her battle with the disease in 2009. Stefanie and her husband Chris Spielman, an All-Star linebacker from Massillon, Ohio and 11-year NFL player, became advocates for the fight against breast cancer, founding the Stefanie Spielman Fund for Breast Cancer Research in 1998. The fund has raised more than $25 million to support research at the OSUCCC – James. To learn more about the Stefanie Spielman Fund for Breast Cancer Research, visit www.spielmanfund.com.
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, please visit cancer.osu.edu.